Noriyasu Haginoya

This inventor holds 13 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Daiichi Pharmaceutical Co., Ltd.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyasu Haginoya. Retrieved from https://idiyas.com/inventor/noriyasu-haginoya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 6)

% Patents Active = 61.5

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 9.1

ph-index = 7

Forward Citations = 120(Granted Patents)

Location History:

Chiba, JP (2013 - 2014)
Tokyo, JP (2003 - 2021)
Chuo-ku, JP (2022 - 2024)

Company Filing History:

7 out of 463

Daiichi Sankyo Company, Limited

patents

6 out of 200

Daiichi Pharmaceutical Co., Ltd.

patents

Years Active: 2003-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528822 - Cycloalkane-1,3-diamine derivative (2026-01-20),

2. 12060365 - Cycloalkane-1,3-diamine derivative (2024-08-13),

3. 11236106 - Cycloalkane-1,3-diamine derivative (2022-02-01),

4. 11208403 - Pyridone derivatives having tetrahydropyranylmethyl groups (2021-12-28),

5. 10442797 - Pyridone derivatives having tetrahydropyranylmethyl groups (2019-10-15),

6. 8785438 - Imidazopyridin-2-one derivatives (2014-07-22),

7. 8436012 - Imidazopyridin-2-one derivatives (2013-05-07),

8. 7935824 - Ethylenediamine derivatives (2011-05-03),

9. 7576135 - Diamine derivatives (2009-08-18),

10. 7342014 - Diamine derivatives (2008-03-11),

11. 7192968 - Ethylenediamine derivatives (2007-03-20),

12. 6747023 - Sulfonyl derivatives (2004-06-08),

13. 6525042 - Sulfonyl derivatives (2003-02-25),

Title: Inventor Spotlight: Noriyasu Haginoya

Introduction: Noriyasu Haginoya, based in Tokyo, Japan, is a prominent inventor known for his innovative contributions in the field of pharmaceuticals. With a total of 12 patents to his name, Haginoya has significantly impacted medical research and drug development.

Latest Patents: Among his latest inventions is a cycloalkane-1,3-diamine derivative, which provides a compound or a pharmaceutically acceptable salt exhibiting an inhibitory action on the interaction between menin and an MLL protein. This invention is represented by a specific formula, where various elements, denoted by R, Ring Q, W, m, and n, are defined in the detailed description. This compound could potentially play a crucial role in therapeutic applications.

Career Highlights: Haginoya's professional journey includes working with notable companies such as Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited. His tenure at these establishments allowed him to refine his skills and contribute to cutting-edge research in the pharmaceutical industry.

Collaborations: Throughout his career, Haginoya has collaborated with esteemed colleagues, including Tsutomu Nagata and Kenji Yoshikawa. These partnerships have been instrumental in fostering innovation and advancing research efforts within the companies he has served.

Conclusion: Noriyasu Haginoya stands out as an accomplished inventor, significantly contributing to the pharmaceutical landscape in Japan and beyond. With his latest patent focused on groundbreaking medical compounds, he continues to inspire upcoming inventors and researchers in the field of medicine.

Profile summary based on public USPTO records.